NCT07895316 Effect of a Constipation Prevention Checklist in Hip Surgery Patients
| NCT ID | NCT07895316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cumhuriyet University |
| Condition | Constipation |
| Study Type | INTERVENTIONAL |
| Enrollment | 124 participants |
| Start Date | 2026-10-12 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 124 participants in total. It began in 2026-10-12 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Constipation is a common postoperative problem in patients undergoing hip surgery and may be associated with immobilization, opioid analgesic use, and inadequate fluid and fiber intake. Preventive interventions, including adequate fluid and nutritional intake, early mobilization, and abdominal massage, may help maintain bowel function. However, evidence regarding the effectiveness of a standardized checklist to guide and monitor these interventions throughout the perioperative period remains limited. This randomized controlled trial aims to determine the impact of monitoring the risk of perioperative constipation and prevention interventions using a standard checklist on bowel sounds, postoperative constipation severity, and quality of recovery in hip surgery patients. The checklist includes a systematic assessment of constipation risk and monitoring of preventive interventions, including fluid and nutrient intake, early mobilization, and abdominal massage. The findings may contribute to improving perioperative nursing care and constipation prevention in patients undergoing hip surgery.
Eligibility Criteria
Inclusion Criteria: * Patients who will undergo primary hip surgery due to a fracture, * 18 years of age and older, * Able to communicate in Turkish and possess the cognitive/communicative competence to respond to data collection tools, * Without hearing problems that would impede communication (including those using hearing aids), * Expected to be monitored for at least 3 days postoperatively, * Patients who volunteer to participate in the study and provide written informed consent. Exclusion Criteria: * Patients with diagnosed chronic constipation, irritable bowel syndrome, or inflammatory bowel disease, * Patients with a history of gastrointestinal surgery or a stoma, * Patients with acute abdomen, suspected bowel obstruction, gastrointestinal perforation, active gastrointestinal bleeding, etc., * Patients with abdominal wall or abdominal clinical conditions that prevent abdominal massage, * Patients with contraindications for mobilization and who have an external fixator, * Patients with (Mini Cognitif Test) Mini-Cog \<3, * Patients with active psychiatric illness that would prevent participation in the study or data collection process, * Patients with American Society of Anesthesiologists IV or V (ASA IV or V), * Patients whose surgery has been postponed, * Patients who have undergone secondary hip surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07895316 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Constipation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07895316 currently recruiting?
Yes, NCT07895316 is actively recruiting participants. Contact the research team at aysegulkayagk@gmail.com for enrollment information.
Where is the NCT07895316 trial being conducted?
This trial is being conducted at Sivas, Turkey (Türkiye).
Who is sponsoring the NCT07895316 clinical trial?
NCT07895316 is sponsored by Cumhuriyet University. The trial plans to enroll 124 participants.